- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-786/18: Judgment of the Court (Third Chamber) of 11 June 2020 (request for a preliminary ruling from the Bundesgerichtshof — Germany) — ratiopharm GmbH v Novartis Consumer Health GmbH (Reference for a preliminary ruling — Protection of public health — Internal market — Medicinal products for human use — Directive 2001/83/EC — Advertising — Article 96 — Distribution of free samples of medicinal products to persons qualified to prescribe them — Pharmacists excluded from the distribution of free samples of medicinal products — Inapplicability to distribution of free samples of non-prescription medicinal products — Consequences for the Member States)
ECLI:EU:UNKNOWN:62018CA0786
62018CA0786
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
17.8.2020
Official Journal of the European Union
C 271/8
(Case C-786/18) (*)
(Reference for a preliminary ruling - Protection of public health - Internal market - Medicinal products for human use - Directive 2001/83/EC - Advertising - Article 96 - Distribution of free samples of medicinal products to persons qualified to prescribe them - Pharmacists excluded from the distribution of free samples of medicinal products - Inapplicability to distribution of free samples of non-prescription medicinal products - Consequences for the Member States)
(2020/C 271/10)
Language of the case: German
Referring court
Parties to the main proceedings
Applicant: ratiopharm GmbH
Defendant: Novartis Consumer Health GmbH
Operative part of the judgment
Article 96(1) of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, as amended by Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, must be interpreted as precluding pharmaceutical companies from distributing free samples of medicinal products to pharmacists. On the other hand, that provision does not preclude distributing free samples of non-prescription medicinal products to pharmacists.
(*) Language of the case: German.